Your browser doesn't support javascript.
loading
Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study.
Brédart, Anne; De Pauw, Antoine; Tüchler, Anja; Lakeman, Inge M M; Anota, Amélie; Rhiem, Kerstin; Schmutzler, Rita; van Asperen, Christi J; Devilee, Peter; Stoppa-Lyonnet, Dominique; Kop, Jean-Luc; Dolbeault, Sylvie.
Afiliación
  • Brédart A; Institut Curie, Supportive Care Department, Psycho-oncology Unit, PSL University, Paris, France.
  • De Pauw A; Psychology Institute, Psychopathology and Health Process Laboratory, University of Paris, Boulogne-Billancourt, France.
  • Tüchler A; Institut Curie, Cancer genetic clinic, PSL University, University of Paris, Paris Cedex 05, France.
  • Lakeman IMM; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Anota A; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
  • Rhiem K; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.
  • Schmutzler R; Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon, France.
  • van Asperen CJ; Human and Social Sciences Department, Centre Léon Bérard, Lyon, France.
  • Devilee P; French National Platform Quality of Life and Cancer, Centre Léon Bérard, Lyon, France.
  • Stoppa-Lyonnet D; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Kop JL; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
  • Dolbeault S; Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Clin Genet ; 102(1): 30-39, 2022 07.
Article en En | MEDLINE | ID: mdl-35508697
ABSTRACT
Counseling for familial breast cancer focuses on communicating the gene test result (GENE) to counselees, but risk prediction models have become more complex by including non-genetic risk factors (NGRF) and polygenic risk scores (PRS). We examined genetic clinicians' confidence in counseling and counselees' psychosocial outcomes, using the BOADICEA risk prediction tool with different categories of risk factors as input. A prospective observational study in Dutch, French and German genetic clinics was performed including 22 clinicians, and 406 of 460 (88.3%) eligible cancer-unaffected women at high breast cancer risk assessed at pre-test and 350 (76.1%) at post-test. We performed multilevel analyses accounting for the clinician, and counselees' characteristics. Overall, risk estimates category by GENE versus GENE+ NGRF, or GENE+NGRF+PRS differed in 11% and 25% of counselees, respectively. In multilevel analyses, clinicians felt less confident in counseling when the full model provided lower breast cancer risks than GENE (i.e., in 8% of cases). Older counselees expressed higher breast cancer risk perception and worries about the hereditary predisposition when the full model provided higher breast cancer risks than GENE only. Genetic clinicians appear confident with breast cancer risk comprehensive models, which seem only to affect perceptions of older counselees.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Asesoramiento Genético Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Genet Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Asesoramiento Genético Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Genet Año: 2022 Tipo del documento: Article País de afiliación: Francia